January 20, 2021
This technical note describes the NGS assays developed by Canexia Health for somatic testing of adult solid tumors and how they are made available through local laboratories via our proprietary technology transfer model.
Imagia Canexia Health’s complete implementation workflow empowers clinical labs to deploy cancer genomic testing from within their own facilities.
We’re here to support you, every step of the way. Joining our partner network means:
Your dedicated Imagia Canexia Health alliance manager helps guide your organization to success and remains your ongoing contact for support and maintenance throughout the partnership. Our streamlined process allows you to generate a rapid return on your organization’s investment.